Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours

Journal of Molecular Endocrinology

Volumn 48, Issue 3, 2012, Pages 193-202

  Karger, Stefan ^a   Krause, Kerstin ^a   Engelhardt, Cornelia ^a   Weidinger, Carl ^a   Gimm, Oliver ^b   Dralle, Henning ^b   Sheu Grabellus, Sien Yi ^c   Schmid, Kurt Werner ^c   Fuhrer, Dagmar ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; ATM PROTEIN; DNA; ENDONUCLEASE; HISTONE H2AX; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN OGG1; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER PROGNOSIS; CANCER STAGING; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANOSINE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXIDATIVE STRESS; RATS; SEX FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84861139727     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0119     Document Type: Article

References (39)

1. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR et al. 2002 Inherited variants of MYH associated with somatic G:C/T:A mutations in colorectal tumors. Nature Genetics 30 227-232. (doi:10.1038/ng828)
2. van Attikum H & Gasser SM 2009 Crosstalk between histone modifications during the DNA damage response. Trends in Cell Biology 19 207-217. (doi:10.1016/j.tcb.2009.03.001)
3. Bartkova J, Horejsi Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C et al. 2005 DNA damage response as a candidate anti cancer barrier in early human tumorigenesis. Nature 434 864-870. (doi:10.1038/nature03482)
4. Beckmann KB & Ames BN 1997 Oxidative decay of DNA. Journal of Biological Chemistry 272 19633-19636. (doi:10.1074/jbc.272.32.19633)
5. Carlini M, Giovannini C, Castaldi F, Mercadante E, Dell'Avanzato R, Zazza S, Nania A, Santeusanio G, Passeri M & di Perna P 2005 High risk for micro carcinoma in thyroid benign diseases. Incidence in a one year period of total thyroidectomies. Journal of Experimental & Clinical Cancer Research 24 231-236.
6. Dal Maso L, Lise M, Zambon P, Falcini F, Crocetti E, Serraino D, Cirilli C, Zanetti R, Vercelli M, Ferretti S et al. & for AIRTUM Working Group 2011 Incidence of thyroid cancer in Italy, 1991- 2005: time trend and age-period-cohort effects. Annals of Oncology 22 957-963. (doi:10.1093/annonc/mdq467)
7. David SS, O'Shea VL & Kundu S 2007 Base-excision repair of oxidative DNA damage. Nature 447 941-950. (doi:10.1038/nature05978)
8. de Deken X, Wang D, Dumont JE & Miot F 2002 Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. Experimental Cell Research 15 187-196. (doi:10.1006/excr.2001.5444)
9. Driessens N, Versteyhe S, Ghaddhab C, Burniat A, De Deken X, Van Sande J, Dumont JE, Miot F & Corvilain B 2009 Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ. Endocrine- Related Cancer 16 845-856. (doi:10.1677/ERC-09-0020)
10. Fagin JA 2002 Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Molecular Endocrinolgy 16 903-911. (doi:10.1210/me.16.5.903)
11. Gasparre G, Bonora E, Tallini G & Romeo G 2010 Molecular features of thyroid oncocytic tumors. Molecular and Cellular Endocrinology 28 67-76. (doi:10.1016/j.mce.2010.02.022)
12. Hoeijmakers JH 2009 DNA damage, aging, and cancer. New England Journal of Medicine 361 1475-1485. (doi:10.1056/NEJMra0804615)
13. Hu J, Xia X, Cheng A, Wang G, Luo X, Reed MF, Fojo T, Oetting A, Gong J & Yen PM 2008 A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Molecular Cancer Therapeutics 7 3719-3728. (doi:10.1158/1535-7163.MCT-08-0499)
14. Husmann G, Kaatsch P, Katalinic A, Bertz J, Haberland J, Kraywinkel K & Wolf U 2010 Cancer in Germany 2005/2006. Incidence and trends. 7th edn. Eds Robert Koch Institute and Association of Population-based Cancer Registries in Germany. Berlin.
15. Jackson SP & Bartek J 2009 The DNA-damage response in human biology and disease. Nature 461 1071-1078. (doi:10.1038/nature08467)
16. Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H & Fuhrer D 2009 FOXO3a: a novel player in thyroid carcinogenesis? Endocrine-Related Cancer 16 189-199. (doi:10.1677/ERC-07-0283)
17. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T & Barnes DE 1999 Accumulation of premutagenic DNA lesions inmice defective in removal of oxidative base damage. PNAS 96 13300-13305. (doi:10.1073/pnas.96.23.13300)
18. Köhrle J, Jakob F, Contempre B & Dumont JE 2005 Selenium, the thyroid, and the endocrine system. Endocrine Reviews 26 944-984. (doi:10.1210/er.2001-0034)
19. Kondo T, Ezzat S & Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nature Reviews. Cancer 6 292-306. (doi:10.1038/nrc1836)
20. Kong Q & Lin CL 2010 Oxidative damage to RNA: mechanisms, consequences, and diseases. Cellular and Molecular Life Sciences 67 1817-1829. (doi:10.1007/s00018-010-0277-y)
21. Krause K, Karger S, Schierhorn A, Poncin S, Many MC & Fuhrer D 2007 Proteomic profiling of cold thyroid nodules. Endocrinology 148 1754-1763. (doi:10.1210/en.2006-0752)
22. Krause K, Eszlinger M, Gimm O, Karger S, Engelhardt C, Dralle H & Fuhrer D 2008 TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency. Journal of Clinical Endocrinology and Metabolism 93 1390-1393. (doi:10.1210/jc.2006-1255)
23. Krause K, Prawitt S, Eszlinger M, Ihling C, Sinz A, Schierle K, Gimm O, Dralle H, Steinert F, Sheu SY et al. 2011 Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma. American Journal of Pathology 179 3066-3074. (doi:10.1016/j.ajpath.2011.08.033)
24. Kreutzer DA & Essigmann JM 1998 Oxidized, deaminated cytosines are a source of C/T transitions in vivo. PNAS 95 3578-3582. (doi:10.1073/pnas.95.7.3578)
25. Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S & Paschke R 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocrine Reviews 26 504-524. (doi:10.1210/er.2004-0005)
26. Liu S, Semenciw R, Ugnat AM & Mao Y 2001 Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-periodcohort effects. British Journal of Cancer 85 1335-1339. (doi:10.1054/bjoc.2001.2061)
27. van Loon B, Markkanen E & Hübscher U 2010 Oxygen as a friend and enemy: how to combat themutational potential of 8-oxo-guanine. DNA Repair 9 604-616. (doi:10.1016/j.dnarep.2010.03.004)
28. Maier J, van Steeg H, van Oostrom C, Karger S, Paschke R & Krohn K 2006 Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147 3391-3397. (doi:10.1210/en.2005-1669)
29. Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, Aburatani H et al. 2000 Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. PNAS 97 4156-4161. (doi:10.1073/pnas.050404497)
30. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29 e45. (doi:10.1093/nar/29.9.e45)
31. Porcelli AM, Ghelli A, Ceccarelli C, Lang M, Cenacchi G, Capristo M, Pennisi LF, Morra I, Ciccarelli E, Melcarne A et al. 2010 The genetic and metabolic signature of oncocytic transformation implicates HIF1a destabilisation. Human Molecular Genetics 19 1019-1032. (doi:10.1093/hmg/ddp566)
32. Rosenquist TA, Zharkov DO & Grollman AP 1997 Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. PNAS 94 7429-7434. (doi:10.1073/pnas.94.14.7429)
33. Russo MT, de Luca G, Degan P & Bignami M 2007 Different DNA repair strategies to combat the threat from 8-oxoguanine. Mutation Research 614 69-76. (doi:10.1016/j.mrfmmm.2006.03.007)
34. Song Y, Driessens N, Costa M, de Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, van Sande J, Many M-C et al. 2007 Roles of hydrogen peroxide in thyroid physiology and disease. Journal of Clinical Endocrinology and Metabolism 92 3764-3773. (doi:10.1210/jc.2007-0660)
35. Song Y, Ruf J, Lothaire P, Dequanter D, Andry G, Willemse E, Dumont JE, Van Sande J & De Deken X 2010 Association of duoxes with thyroid peroxidise and its regulation in thyrocytes. Journal of Clinical Endocrinology and Metabolism 95 375-382. (doi:10.1210/jc.2009-1727)
36. Shattuck TM, Westra WH, Ladenson PW & Arnold A 2005 Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. New England Journal of Medicine 352 2406-2412. (doi:10.1056/NEJMoa044190)
37. Tanaka T, Huang X, Jorgensen E, Gietl D, Traganos F, Darzynkiewicz Z & Albino AA 2007 ATM activation accompanies histone H2AX phosphorylation in A549 cells upon exposure to tobacco smoke. BMC Cell Biology 8 26. (doi:10.1186/1471-2121-8-26)
38. Volzke H, Ludemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U & Meng W 2003 The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 13 803-810. (doi:10.1089/105072503768499680)
39. Vonate M, Croce S, Pecchioni C & Papotti M 2002 E2F-1 transcription factor is overexpressed in oxyphilic thyroid tumours. Modern Pathology 15 1038-1043. (doi:10.1097/01.MP.0000028645.36632.A8)